Advertisement

Topics

Search Results for "India Anty Sex"

15:16 EST 7th December 2016 | BioPortfolio

Matching Channels

India ink colloidal carbon stain

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

Matching News

Dun & Bradstreet India launches first edition of India's leading pharma cos

The significance of India's pharmaceuticals sector can be gauged from the fact that in FY16, India's exports of pharmaceutical products stood at USD 16.9 billion, which was about 5 per cent of the agg...

HealthCare at Home India to invest Rs. 100 cr for pan─India expansion, team strength to upto 1,000

HealthCare at Home (HCH) India, a joint venture between the Burman family, the promoters of Dabur Group and founders of Health Care At Home, UK is slating a Rs. 100 crore investment for its pan─Indi...

GE Healthcare doubles India investment

UK firm GE Healthcare is set to double its investment in India as it aims for revenues of £750 million this year, according to CEO John Flannery. "India influences a lot about how I think about the g...

analytica Anacon India and India Lab Expo 2016 in the starting blocks

analytica Anacon India and India Lab Expo, leading trade fairs for laboratory technology, analysis, biotechnology and diagnostics is scheduled from October 20 to 22 at the HITEX Exhibition Center, Hy...

Fosun Pharma to Pay $1.3 Billion for India's Gland Pharma in Historic Deal

Shanghai Fosun Pharma won the bidding war for India’s Gland Pharma, paying $1.3 billion for a 86% stake. Gland makes generic injectible drugs. Most of Gland's revenues come from the US, although...

Fosun Pharma to Pay $1.4 Billion for India's Gland Pharma in Historic Deal

Shanghai Fosun Pharma won the bidding war for India’s Gland Pharma, paying $1.4 billion for a 96% stake. Gland makes generic injectible drugs. Most of Gland's revenues come from the US, although...

'Make in India' strategy to kickstart domestic biomanufacturing, Biocon

A lack of investment and government support has stunted biomanufacturing in India, but Biocon says this will change through the country’s 'Make in India' programme.

India’s NEET exam poses problems in its current form

Supe’s article on India’s National Eligibility-cum-Entrance Test (NEET) was interesting.1 In reality, however, some disadvantages arise from conducting the test in its present form.States in India...

Matching PubMed Articles

Eclampsia in India Through the Decades.

Eclampsia is still prevalent in India with high maternal and perinatal mortality. In India, there is no community-based survey of eclampsia. Sporadic reports of study on eclampsia are being published ...

The Sericothripinae genus Neohydatothrips (Thysanoptera, Thripidae) in India with description of two new species.

Two new species of Neohydatothrips are described from India, N. chandrai and N. plumeria. The former was collected on leaves of a hedge plant in northwest India, and the latter on flowers and leaves o...

Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis.

India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India's phar...

The Human Cost of Tobacco Chewing Among Pregnant Women in India: A Systematic Review and Meta-analysis.

In India, smokeless tobacco (SLT) use among pregnant women is high and its adverse effects on pregnancy outcomes have not been properly documented in.

Ataxia due to isolated vitamin E deficiency from South India.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement